To our knowledge, this is the first examination to demonstrate the overexpression of RRBP1 in epithelial ovarian cancer and to suggest that RRBP1 may be a valuable prognostic biomarker for epithelial ovarian cancer. Here, RRBP1 is linked to ovarian carcinoma.